Medications

Atezolizumab prolongs survival in NSCLC with PD-L1 expression

(HealthDay)—For patients with non-small cell lung cancer (NSCLC) with programmed death ligand 1 (PD-L1) expression, treatment with atezolizumab results in longer overall survival than chemotherapy, according to a study ...

Medications

Breast cancer medication risk

New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.

Oncology & Cancer

Immunotherapy offers hope for prostate cancer treatment

An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the finding of the long-term analyses of an international phase ...

Oncology & Cancer

Women may conceive after ovarian tumors

Women receiving fertility-sparing surgery for treatment of borderline ovarian tumors were able to have children, a study from Karolinska Institutet in Sweden published in Fertility & Sterility shows. Natural fertility was ...

page 1 from 72